Shopping Cart 0
Cart Subtotal
USD 0

OTC Drug

OTC

Showing Repository 1-10 of 672 Reports

per page
Single User License Price
  1. Global Marine Derived Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

    116 Pages| June 2019 |
    USD 4880
    The classification of Marine Derived Drugs includes mollusk sources, Sponge sources, tunicate sources, fish sources and others. And the proportion of mollusk sources is occupied 49.40% of global revenue market share in 2018. Learn More
  2. Global Chemotherapy Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024

    120 Pages| June 2019 |
    USD 4880
    The global Chemotherapy Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. Learn More
  3. Global Antiretroviral Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024

    118 Pages| June 2019 |
    USD 4880
    The global Antiretroviral Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. Learn More
  4. Global Targeted Drug BRAF Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024

    100 Pages| June 2019 |
    USD 4880
    The global Targeted Drug BRAF Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. Learn More
  5. Global Targeted Drug MEK Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024

    109 Pages| June 2019 |
    USD 4880
    The global Targeted Drug MEK Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. Learn More
  6. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024

    107 Pages| June 2019 |
    USD 4880
    The global Targeted Drug VEGFR2 Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. Learn More
  7. Global Targeted Drug VEGF Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024

    120 Pages| June 2019 |
    USD 4880
    The global Targeted Drug VEGF Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. Learn More
  8. Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market 2019 by Company, Regions, Type and Application, Forecast to 2024

    136 Pages| June 2019 |
    USD 4880
    The global Non-Peptide Drugs of Angiotensin II Receptor Antagonist market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. Learn More
  9. Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024

    139 Pages| June 2019 |
    USD 4880
    The global Targeted Drug EGFR RTK Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. Learn More
  10. Global Metoprolol Combination Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

    124 Pages| June 2019 |
    USD 4880
    The global Metoprolol Combination Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. Learn More
Loading Indicator